News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Clinical - Drug Product News
Rhodes Pharmaceuticals Announces Launch Of New, Once-Daily Treatment For ADHD 5/22/2015
New FDA Warning Impacts Diabetes Drugs Made by AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) and Eli Lilly (LLY) 5/21/2015
Pfizer (PFE) Release: America's Most-Preferred Multivitamin Brand Launches New Centrum MultiGummies 5/21/2015
Pharmatek Expands Spray Drying Capabilities 5/20/2015
Osteo Bi-Flex Introduces EASE Mini-Tabs: Collagen-Based Formula For Every Day Joint Comfort 5/20/2015
Neos Therapeutics Announces Trade Name Cotempla XR-ODT For Its Methylphenidate Extended-Release Orally Disintegrating Tablets 5/20/2015
Lakewood-Amedex Inc. Announces Its Novel Bisphospocin Class Of Antimicrobials Kills Multidrug Resistant-Tuberculosis (MDR-TB) Strains In Fifteen Minutes 5/19/2015
S-BIO Launching BlotGlyco O-Glycan Sample Preparation Kit In U.S., Japan 5/19/2015
Encore Dermatology A New Specialty Dermatology Company 5/19/2015
Endo International (ENDP) Announces Updated XIAFLEX Label With Recurrence And Retreatment Data In Patients With Dupuytren's Contracture 5/18/2015
Actavis (ACT) Launches NAMZARIC (memantine hydrochloride Extended-Release And donepezil hydrochloride), A Fixed-Dose Combination Therapy For The Treatment Of Moderate To Severe Alzheimer's Disease 5/18/2015
BMG Pharma S.r.l Announces The Launch Of Its Proprietary Product Ialuxid Gel Under The New Trademark HPO Skin Protect Owned By Centro Internacional De Cosmiatria, S.A.P.I. De C.V. ("FARMAPIEL") In Mexico 5/18/2015
EyePromise Introduces EyePromise vizual EDGE Chewable, A Once-Daily Orange Citrus Flavored Chewable Designed To Help Athletes See Better And React Faster 5/18/2015
Klox Technologies Launches Its Commercial Activities For Lumiheal In Europe For The Treatment Of Chronic, Acute And Surgical Wounds Along With Burns 5/15/2015
Zambon Launches Xadago (Safinamide) For Patients With Mid- To Late-Stage Parkinson’s Disease In Germany 5/15/2015
Iroko Pharmaceuticals Announces First International Launch Of ZORVOLEX 5/14/2015
Hikma Pharmaceuticals (HIK.L) Launches Caffeine Citrate Injection, Commercialising The First Of The Bedford Products 5/12/2015
Axxess Pharma, Inc.'s All-Natural Tapout Products Now Available In Large North American Fitness Chain 5/12/2015
Actavis (ACT) To Re-Launch Generic Pulmicort Respules Following Favorable Appeals Court Ruling 5/8/2015
Apricus Biosciences (APRI) Announces The Launch Of Its Novel Topical Treatment For Erectile Dysfunction In Spain By Recordati S.p.A 5/6/2015
Beike Biotechnology Produces High-Dose Adult Stem Cell Packets For Degenerative Conditions 5/6/2015
Mylan (MYL) Launches Generic Seasonale Tablets 5/5/2015
Mylan (MYL) Launches Gilead (GILD)' Sovaldi Tablets In India 5/4/2015
Pernix (PTX) Launches Zohydro ER With BeadTek 5/4/2015
Chinese Men Spark a 47% Surge in Viagra Sales for Pfizer (PFE) 5/4/2015
Amyris, Inc. Hosts Event To Preview Launch Of Biossance Brand 5/1/2015
AOP Orphan Pharmaceuticals AG Launches Lojuxta (Lomitapide) For Treatment Of Homozygous Familial Hypercholesterolaemia To The Austrian Market 4/30/2015
Teva (TEVA) Launches Generic Abilify Tablets In The United States 4/29/2015
Teva (TEVA) Continues To Invigorate Injectable Portfolio With The Launch Of Argatroban Injection In The United States 4/28/2015
Vetter Serializes the First Product for South Korea 4/28/2015
MannKind Corporation (MNKD) To Manufacture 12 Unit Cartridge Strength Of AFREZZA Following FDA Approval 4/27/2015
DS Healthcare Begins Shipping Its Hair Regrowth Tablets Integra On May 8th 4/27/2015
Astellas Pharma Inc. (ALPMY) Launches CRESEMBA (isavuconazonium sulfate) In The United States For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis 4/27/2015
Pivotal Therapeutics Inc. Receives Health Canada Approval To Expand The Indication Of OMAZEN To Include Products With Claims To Maintain And Support Cardiovascular Health And Normal Triglyceride Levels 4/27/2015
Aceto Corporation Subsidiary, Rising Pharmaceuticals, Inc, To Launch Timolol Maleate Ophthalmic Solution And Ofloxacin Ophthalmic Solution 4/24/2015
Mylan (MYL) Launches Generic Sofosbuvir Tablets, MyHep, In India 4/23/2015
Actavis (ACT) Launches AVYCAZ (Ceftazidime-Avibactam) Anti-Infective In U.S. 4/23/2015
Novo Nordisk A/S (NVO) Announces Saxenda (Liraglutide [Rdna Origin] Injection) Is Now Commercially Available In The United States 4/22/2015
Elite Pharmaceuticals, Inc. (ELI) Announces Launch Of Generic Hydroxyzine Tablets 4/21/2015
Roche Canada Release: Prince Edward Island Adds PERJETA-HERCEPTIN Combo Pack For Treatment Of HER2-Positive Metastatic Breast Cancer To The Provincial Formulary 4/21/2015
Alimera Sciences (ALIM) Release: ILUVIEN Is Now Widely Available To Diabetic Macular Edema Patients Throughout The U.S. 4/21/2015
Huntingdon Life Sciences And Harlan Laboratories, Inc. Announce The Launch Of The SHrN™ Novel Hairless NOD.SCID Model At AACR 2015 4/20/2015
Immuron (ASX:IMC) Announces First USA Orders For Travelan 4/20/2015
BioPharmX Announces Violet Iodine is Now Available At The Vitamin Shoppe 4/20/2015
Lupin Ltd. (LUPN.BO) Launches Zaxine In Canada 4/20/2015
Perrigo (PRGO) Announces The Launch Of A Generic Version Of Kenalog Nasal Spray 4/17/2015
Eli Lilly (LLY) Snags North American Rights to Erbitux From Bristol-Myers Squibb (BMY) 4/16/2015
FDA Panel Wants Heart Risk Warnings for AstraZeneca PLC (AZN), Takeda (TKPYY) Diabetes Drugs 4/16/2015
RevMedx Announces First Product Shipments of XSTAT To US Military. 4/16/2015
22nd Century Group, Inc. Announces Launch Of “0.0 Mg Nicotine” MAGIC Cigarettes In Spain 4/16/2015
Pharma Giant GlaxoSmithKline (GSK) to Battle Rowex Over Purple Design of a New Inhaler 4/15/2015
Actavis (ACT) Owes No Apology for Seeking New Alzheimer's Drug Profits, Says Lawyer 4/14/2015
Pfizer (PFE) Researchers Allegedly Knew About Zoloft's Birth Defect Risk 4/14/2015
Actavis (ACT) And Medicines360 Announce U.S. Availability Of LILETTA (levonorgestrel-releasing intrauterine system) 52 Mg To Prevent Pregnancy For Up To Three Years 4/14/2015
Sanofi (SAN.PA) Korea Launches Anlit Probiotic Supplement For Kids 4/14/2015
Sanofi (SAN.PA) Stuck Between a Rock and a Hard Place With Lantus Heir Toujeo 4/13/2015
Actavis (ACT) And Medicines360 Announce U.S. Availability Of LILETTA (levonorgestrel-Releasing Intrauterine System) 52 Mg To Prevent Pregnancy For Up To Three Years 4/13/2015
Sagent Pharma Announces The Launch Of Vancomycin Hydrochloride For Injection, USP 4/13/2015
European Medicines Agency's PRAC Recommends Updating Advice On Use Of High Dose Ibuprofen 4/13/2015
Death Possibly Linked to Biogen (BIIB) Tecfidera "No Cause for Alarm," Says Analyst 4/10/2015
Cardiome Pharma Corp. (COM.TO) Receives BRINAVESS Reimbursement Approval From Belgian Authorities 4/10/2015
Alexion (ALXN) Receives Approval For Important Updates To The European Label For Soliris (Eculizumab) 4/10/2015
Nielsen BioSciences' SPHERUSOL Provides Physicians With New Test For Valley Fever 4/9/2015
Perrigo (PRGO) Announces FDA Approval And Upcoming Launch Of The AB Therapeutic Equivalent To Exalgo 4/8/2015
Why the Flu Vaccine Barely Worked This Year 4/8/2015
Mylan (MYL) Launches First Generic Version Of Generess Fe 4/7/2015
VisiVite Launches AREDS2 E-Free Blue Formula: Macular Support For Those On Anticoagulant Therapies 4/7/2015
SAFC Launches New EX-CELL Advanced Products For Scalable, Efficient Biopharmaceutical Manufacturing 4/7/2015
Analyst: A Complete List of All Major Biosimilars Could Be the A to Z Guide 4/6/2015
Novartis AG (NVS) Accused of "Bullying" Doctors to Drop Trial of Cheaper Drugs 4/6/2015
Pfizer (PFE) Halts China Vaccine Business After Import License is Killed; 200 Employees Impacted 4/3/2015
Should Gilead (GILD) Feel Threatened by Achillion (ACHN)'s Next-Generation Hep C Drug? 4/3/2015
Omeros Corporation (OMER) Announces The U.S. Commercial Launch Of Omidria 4/2/2015
Merck & Co. (MRK)'s HPV Vaccine, GARDASIL9, Now Available In Canada 4/1/2015
Shire (SHPGY) Release: Natpara (Parathyroid Hormone) For Injection Now Available In The U.S. 4/1/2015
Ducere Pharma to Relaunch Ex-Novartis AG (NVS) Cruex Antifungal 4/1/2015
Pfizer (PFE) Ad Spending Dwarfs Competitors 3/31/2015
Ferring Pharmaceuticals Receives FDA Approval For Growth Hormone Name Change, Acquires ZOMACTON [Somatropin (rDNA Origin)] For Injection And Needle-Free Device In The U.S. 3/31/2015
ANI Pharmaceuticals, Inc. Announces The Launch Of Propafenone Tablets 3/31/2015
Nektar Therapeutics (NKTR) Release: MOVANTIK (Naloxegol) Tablets For The Treatment Of Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pain Launched In The US 3/31/2015
Mylan (MYL) Launches Generic Exforge Tablets 3/31/2015
Teva (TEVA) Expands Hypertension Line With Launch Of Generic Exforge Tablets In The United States 3/31/2015
VIVUS, Inc. (VVUS) Updates On Qsymia Plans; Will Continue Talks With U.S., EU Regulators 3/31/2015
PHEBURANE Now Available For Distribution In Canada Through Medunik Canada 3/30/2015
Par Specialty Pharmaceuticals Launches Nascobal (Cyanocobalamin, USP) Nasal Spray Single-Use Device Along With Nascobal Nutrition Direct Progrm 3/30/2015
Hospira's INFLECTRA (Infliximab) Now Available In Canada 3/30/2015
Janssen Research & Development Release: FDA Approves Label Update For ZYTIGA To Include Statistically Significant Overall Survival Results In Chemotherapy-Naive Men With Metastatic Castration-Resistant Prostate Cancer 3/30/2015
Novo Nordisk (NJ) (NVO)To Launch Novoeight In The United States For People With Hemophilia A 3/26/2015
Egalet Provides Commercial Update On SPRIX And OXAYDO 3/25/2015
Eli Lilly (LLY) Release: First-In-Class Type 2 Diabetes Treatment Glyxambi (empagliflozin/Linagliptin) Tablets For Adults Now Available In U.S. Pharmacies 3/23/2015
Suneva Medical Introduces Regenica Recovery Gel 3/23/2015
NEOCUTIS Launches MICRO·ESSENTIALS™ Skincare Line Powered By MPC 3/23/2015
Stempeutics Receives Advanced Therapy Medicinal Product (ATMP) Classification From European Medicines Agency For Its Novel Stem Cell Drug 'Stempeucel' 3/23/2015
NeoStrata Company, Inc. Launches SKIN ACTIVE Dermal Replenishment 3/20/2015
Neovasc Inc. (NVC) Launches Reducer In Select European Countries 3/20/2015
Akorn, Inc. (AKN) Launches Phenylephrine HCl Ophthalmic Solution 3/20/2015
Emisphere Technologies, Inc. (EMIS) Launches Eligen B12, The First Oral Prescription Tablet Proven To Normalize B12 Levels Without The Need For An Injection 3/19/2015
Prestium Pharma, Inc. Announces Plans For Release Of Improved OLUX (Clobetasol Propionate) Foam 3/19/2015
Novogen Limited (NVGN) Release: Potential Of Anisina To Become Major New Chemotherapy Confirmed By Coda Study 3/18/2015
Hatchtech Pty Ltd To Explore Strategic Alternatives For Commercialization Of Xeglyze Lotion In The U.S. 3/18/2015
Actavis (ACT) Receives FDA Approval For VIIBRYD (vilazodone HCl) 20mg Once Daily As A Therapeutic Dose 3/17/2015
TWi Pharmaceuticals, Inc. Announces The First Shipment Of Its Generic Product In The U.S. Market 3/17/2015
Duchesnay inc. Release: Expansion Overseas – Diclectin For Nausea And Vomiting Of Pregnancy (NVP) Now Available In Israel 3/17/2015
Allergan (AGN) Rival Ipsen (IPN.PA) to Continue U.S. Hiring Spree 3/16/2015
Endo Pharmaceuticals (ENDP) Announces The Launch Of NATESTO (Testosterone Nasal Gel), The First And Only Nasal Gel For Testosterone Replacement Therapy 3/16/2015
Yisheng Biopharma Co., Ltd. Release: A New Therapeutic Vaccine Successfully Developed Against Rabies 3/16/2015
Merz North America Announces The Availability Of Radiesse (+) With Integral 0.3% Lidocaine 3/16/2015
FDA Rates Kitabis Pak As Therapeutic Equivalent Of TOBI 3/16/2015
Genovis Is Launching A New Enzyme Product 3/12/2015
Mylan Inc. (MYL) Launches First And Only Available Intermediate Dosage Strengths Of Fentanyl Transdermal System 37.5, 62.5 And 87.5 Mcg/Hr 3/11/2015
Mylan Inc. (MYL) Launches Generic Antabuse Tablets 3/11/2015
Take Charge And Become One Of The Alpha Elite With The Launch Of Hantian Labs' Stimulant Free Testosterone And Performance Booster 3/11/2015
Mylan Inc. (MYL) Launches Generic Subutex Sublingual Tablets 3/11/2015
Akorn, Inc. (AKN) Provides Update On Recent Product Launches 3/11/2015
Vectura Group plc (VEC.L) Release: AirFluSal Forspiro Launched In Portugal And Ireland 3/11/2015
Afaxys Pharmaceuticals Announces Launch Of Econtra EZ, Its First Over-The-Counter Emergency Contraceptive 3/11/2015
BioPharmX Announces Violet Iodine Now Available At Leading National Retailer 3/10/2015
Milan, Italy: BMG Pharma S.r.l Announces The Launch Of Its Proprietary Product Ialuxid Gel In The People's Republic Of China By Luqa Pharmaceuticals 3/10/2015
ANI Pharmaceuticals, Inc. Announces The Launch of Etodolac 200mg Capsules 3/10/2015
Colorcon, Inc. Introduces Opadry Amb II – The Next Advancement In Fully Formulated Film Coating Systems For Moisture Barrier Protection Of Pharmaceutical Tablets 3/10/2015
TWi Pharmaceuticals, Inc. Receives Rare Disease Drug Designation For Its Drug Candidate AC-203 In Taiwan 3/10/2015
Actavis (ACT) Launches Generic Version Of Temovate (Clobetasol Cream 0.05%) 3/9/2015
Genentech (RHHBY) Denies Knowledge of Distribution Problems for Cancer Drugs 3/9/2015
Manzo Pharmaceuticals Announces Progress, As Retail Stores Start To Carry Tummy Relief 3/9/2015
Larasan Release: FLEX24, New All-Natural Pain Reliever Lasts 24 Hours, Longer Than Other OTC Pain Relievers; Innovative Performance Tape A First In The Market 3/9/2015
AbbVie (ABBV) CEO Believes New Form of Humira Could Confront Generics 3/6/2015
Orexo US Launches New 8.6/2.1 Mg ZUBSOLV (Buprenorphine/Naloxone) Sublingual Tablet CIII: 8.6/2.1mg 3/6/2015
Genentech (RHHBY)'s Controversial Distribution Move Deemed a Failure: Survey 3/5/2015
Akorn, Inc. (AKN) to Cease Use of its Drugs in Lethal Injections 3/4/2015
Elder Pharmaceutical Ltd. Forays Into The Rs 800 Crore Nasal Inhaler Segment With Launch Of "Solo" Inhalers 3/2/2015
Ipsen (IPN.PA) Announces Third Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S. In 2015 3/2/2015
Eisai Inc. (ESALF.PK) Release: LENVIMA (lenvatinib) Now Available Through Two Specialty Pharmacies, Accredo And Biologics, Inc. 2/27/2015
Pfizer (PFE) Release: CDC Advisory Committee On Immunization Practices Votes To Recommend Serogroup B Meningococcal Disease Vaccination For Persons At Increased Risk 2/26/2015
After Almost a Year Hiatus, GlaxoSmithKline (GSK)'s Popular Diet Pill alli Returns to Market 2/25/2015
Heritage Pharmaceuticals Initiates A Nationwide Voluntary Recall Of Colistimethate For Injection USP, 150 Mg And Rifampin For Injection USP, 600 Mg/Vial Due To A Lack Of Sterility Assurance 2/25/2015
Celltrion, Inc. (068270.KQ) Launches World’s First Biosimilar Monoclonal Antibody Remsima In 12 New European Markets 2/25/2015
TWi Pharmaceuticals, Inc. Announces That It Will Sell Its Products In The U.S. Market, Originally Planned To Be Sold By Teva, Through Its Wholly-Owned Subsidiary, TWi Pharmaceuticals USA 2/24/2015
Pre-Booking For Flublok Influenza Vaccine Now Available From Cardinal Health, Inc. (CAH) And McKesson Corporation 2/24/2015
Prometheon Pharma Release: Follicept Hair Growth Gel Set For Launch In 2015 By UF Transdermal Delivery Startup 2/24/2015
Celgene International Sárl (CELG) Release: ABRAXANE Now Reimbursed In Italy As A First-Line Treatment Of Adult Patients With Metastatic Pancreatic Cancer 2/24/2015
Critics Attack as Gilead (GILD) Has a Pill to Stop HIV, But Why Isn't Anyone Taking It? 2/23/2015
Tauriga Sciences Inc. (TAUG) Completes Manufacturing Of CannaCaviar CBD Soft Gels 2/23/2015
FDA Grants Seven Years’ Market Exclusivity To Eagle Pharmaceuticals (EGRX)’ Ryanodex For The Treatment Of Malignant Hyperthermia 2/23/2015
Ferring Pharmaceuticals Announces European Launch Of CORTIMENT MMX (Budesonide) For Ulcerative Colitis, And New Data Re-Confirms Safety And Efficacy 2/20/2015
Actavis (ACT) Receives Final Approval For Generic Version Of Subutex 2/20/2015
Aptalis Pharmaceutical Technologies (FRX) Release: Allegra Dry Syrup 5% Launches In Japan 2/20/2015
Teva Pharmaceutical Industries (TEVA) Bolsters Injectable Portfolio With Launch Of Generic Lovenox And Generic Zyvox In The United States 2/17/2015
Galderma Laboratories Announces Availability Of Soolantra® (ivermectin) Cream, 1% 2/17/2015
Hospira Launches First Biosimilar Monoclonal Antibody (mAb) Inflectra (Infliximab) In Major European Markets 2/16/2015
Actavis (ACT) Launches Generic Pulmicort RESPULES 2/16/2015
Teijin Limited Release: Small-sized MUCOSOLVAN L Expectorant Tablet 45 Mg Approved In Japan 2/16/2015
SkinCeuticals Announces The Launch of Metacell Renewal B3 2/13/2015
Gilead (GILD) Agrees to a Discounted Price of $46,000 for Sovaldi in Europe 2/13/2015
Noven Pharmaceuticals Inc. Release: New Minivelle (Estradiol Transdermal System) 0.025 mg/day Dose Now Available by Prescription in U.S. Pharmacies 2/12/2015
Ex-Smokers Jittery About GlaxoSmithKline (GSK)'s Nicorette Lozenge Shortage 2/11/2015
Aratana Therapeutics (PETX) Provides Product Updates 2/11/2015
BioLife Solutions, Inc. (BLFS.OB) Launches New Cell Thawing Media Products In Response To Worldwide Shortage Of Dextran Solutions 2/11/2015
Cumberland Pharmaceuticals (CPIX) Announces Pipeline Expansion With Boxaban (ifetroban) Oral Capsule 2/11/2015
Itonis Pharmaceuticals Distribution Of Its EMESYL(TM) Nausea Relief Seeking Marketing Evaluation To Air Infomercial With 2/11/2015
Itonis Pharmaceuticals's EMESYL(TM) Nausea Relief Convenience Store Test Market Begins In Lodi, California 2/11/2015
Newly Approved Ibrance (Palbociclib) From Pfizer (PFE) Available Through Onco360 2/9/2015
BMG Pharma S.r.l Obtained A New Indication On Molluscum Contagiosium For CE Marked Proprietary Product Ialuxid Gel 2/9/2015
Daiichi Sankyo (4568.t) Release: SAVAYSA (edoxaban) Now Available In U.S. Pharmacies 2/9/2015
Are You At Risk? Bayer HealthCare (BAY)'s Aspirin Launches The Proheart Path Tool To Assess CV Event Risk 2/9/2015
Tianjin Medical University Cancer Hospital Release: Nanocarrier Drugs for Pancreatic Cancer Now Being Produced In China 2/6/2015
AstraZeneca PLC (AZN) Release: MOVANTIK (naloxegol) Tablets Descheduled By The DEA 2/6/2015
Novartis Pharmaceuticals Canada Inc. Release: Now Available In Quebec, Ultibro® Breezhaler®, A Once-Daily Dual Bronchodilator For Chronic Obstructive Pulmonary Disease (COPD) 2/3/2015
Merck & Co. (MRK)’s Insomnia Medicine BELSOMRA® (Suvorexant) C-IV, The First And Only Orexin Receptor Antagonist, Now Available In The United States 2/3/2015
Sanofi (SAN.PA) And MannKind Corporation (MNKD) Announce Afrezza®, The Only Inhaled Insulin, Now Available In The U.S. 2/3/2015
Inergetics, Inc. Completes Final Launch Preparations For Its New CBD-Based Pain Relief Supplement 2/3/2015
Merck & Co. (MRK)'s Fake MMR Trial Data Buried Even as Measles Outbreak Shows Vaccine Surge 2/2/2015
Vertex Pharmaceuticals (MA) (VRTX) Learns From Gilead Sciences, Inc. (GILD)'s Solvadi Mistakes as it Preps for CF Drug Launch 2/2/2015
FDA Approves New Dosing Option for CSL Behring's Hizentra® 2/2/2015
PharmAthene, Inc. (PIP) rPA Antigen Formulated With DepoVax™ Demonstrates Promise As Single Unit Dose Anthrax Vaccine 2/2/2015
Octapharma USA, Inc. Launches Co-Pay Assistance Program For Patients Receiving Wilate® 2/2/2015
ANI Pharmaceuticals, Inc. Announces The Launch Of Etodolac 300mg Capsules 1/30/2015
CytoSorbents, Inc. And Aferetica Introduce CytoSorb® To Italy 1/30/2015
Novartis AG (NVS) Sees Price War With Amgen (AMGN), Eli Lilly (LLY) for Blockbuster Psoriasis Market 1/29/2015
FDA Grants QIDP Designation To Neutrolin®, CorMedix (CRMD)'s Lead Product Candidate In The U.S. 1/29/2015
Asia's Biggest Vaccine Maker a Huge Threat to Drugmakers Like Merck & Co. (MRK) 1/28/2015
Rhinomed (ASX:RNO) Release Of Next Generation Turbine Sports Technology 1/28/2015
BioSpace (DHX) Poll Finds Whopping 92% of Respondents Believe Discounts Were Offered in Pricing War 1/27/2015
MSF Not Impressed With Pfizer (PFE)'s "Tiny" Vaccine Price Cut 1/27/2015
New England Biolabs Releases Rapid PNgase F For Biotherapeutic Development And Production 1/27/2015
IMPAX Laboratories, Inc. (IPXL) Receives FDA Approval For A Generic Version Of Lamictal® Orally Disintegrating Tablets (ODT) 1/26/2015
Purdue Pharma L.P. Release: Hysingla™ ER (hydrocodone bitartrate) Extended-Release Tablets CII Now Available 1/26/2015
Pfanstiehl Laboratories Launches New cGMP-produced, Parenteral Grade Maltose For Pharmaceutical Formulations 1/26/2015
Bogus Versions of Eli Lilly (LLY)'s Cialis Found Entering the U.S. By Mail, Says FDA 1/23/2015
After Gilead (GILD)-AbbVie (ABBV)'s Hep C Price War, Express Scripts Inc. Eyes Cancer Meds Next 1/23/2015
NanoViricides, Inc. (NNVC.PK) Reports That It Has Shipped anti-Ebola Drug Candidates For Testing to a BSL-4 Hi-Security Biocontainment Laboratory 1/22/2015
Disneyland Measles Outbreak Casts Shadow on Anti-Vaccination Movement 1/21/2015
Boehringer Ingelheim Pharmaceuticals, Inc. Release: SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray Now Available In The United States 1/21/2015
International Charity Slams GlaxoSmithKline (GSK), Pfizer (PFE) for High Vaccine Prices 1/20/2015
IDEXX Laboratories, Inc. (IDXX) Announces SDMA As Important Expansion To Reference Lab Test Menu 1/19/2015
Elite Pharmaceuticals, Inc. (ELI) Announces First Shipment Of Generic Isradipine Capsules 1/16/2015
Mylan Inc. (MYL) Launches Generic Epivir-HBV® Tablets 1/16/2015
J.P. Morgan: AbbVie (ABBV) Getting "Very Compelling" Exclusive Offers for Viekira Pak, Says CFO 1/15/2015
Alimera Sciences (ALIM) Announces First Sale Of ILUVIEN® In Portugal 1/14/2015
Eli Lilly (LLY) Claims Innocence as FDA Bans Mystery Cialis-Viagra Concoction Discovered at Plant 1/14/2015
Targets Of Next Express Scripts Inc. Price War: Amgen (AMGN) and Regeneron (REGN) 1/14/2015



//-->